Hiberix (GlaxoSmithKline Biologicals SA)
Welcome to the PulseAid listing for the Hiberix drug offered from GlaxoSmithKline Biologicals SA. This pharmaceutical is classified as a VACCINE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.
LABELER NAME / MANUFACTURER: | GlaxoSmithKline Biologicals SA |
NON-PROPRIETARY NAME: | Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate) |
SUBSTANCE NAME: | |
TYPE: | VACCINE |
PHARMA CLASS: | |
ROUTE: | |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 2015-12-21 |
END MARKETING DATE: | 0000-00-00 |
Hiberix VACCINE Details:
Item Description | Hiberix from GlaxoSmithKline Biologicals SA |
LABELER NAME: | GlaxoSmithKline Biologicals SA |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 2015-12-21 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 58160-818_f7ebe494-1728-47db-b502-b088a8dc3113 |
PRODUCT NDC: | 58160-818 |
APPLICATION NUMBER: | BLA125347 |